Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy Persons
The Effect of Using Preparations With Maqui Berry Extract in Treating Oral Candidiasis in Patients With Diabetes Mellitus and Systemically Healthy Persons
Sponsor: University of Belgrade
This PHASE4 trial investigates Oral Candidiases and is currently ongoing. University of Belgrade leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Jul 2025 — Present [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Sep 2024 — Jul 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jul 2023 — Jul 2024 [monthly]
Recruiting PHASE4
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Belgrade
For direct contact, visit the study record on ClinicalTrials.gov .